KKR Affiliate Loans Food Allergy-Focused Biopharma $170M
An affiliate of private equity giant KKR has agreed to loan Aimmune Therapeutics $170 million to be paid in three separate payments, the food allergy-focused biopharmaceutical company said Friday....To view the full article, register now.
Already a subscriber? Click here to view full article